Category Research

First-Of-Its-Kind Head-to-Head Clinical Trial Reaffirms the Efficacy of Emgality in Episodic Migraine Prevention

First-Of-Its-Kind Head-to-Head Clinical Trial Reaffirms the Efficacy of Emgality in Episodic Migraine Prevention Eli Lilly and Company (NYSE: LLY) announced results of the CHALLENGE-MIG clinical trial of Emgality® (galcanezumab-gnlm) and Nurtec® ODT (rimegepant orally disintegrating tablet), the first and only trial of its…

Read MoreFirst-Of-Its-Kind Head-to-Head Clinical Trial Reaffirms the Efficacy of Emgality in Episodic Migraine Prevention

New blood biomarker can predict if cognitively healthy elderly will develop Alzheimer’s disease

New blood biomarker can predict if cognitively healthy elderly will develop Alzheimer’s disease Why do some people develop Alzheimer’s disease while others don’t? And, even more puzzlingly, why do many individuals whose brains are chock-full of toxic amyloid aggregates –…

Read MoreNew blood biomarker can predict if cognitively healthy elderly will develop Alzheimer’s disease

EUROPEAN STUDY FINDS THE ABBOTT CARDIOMEMS SENSOR RESULTS IN IMPROVED QUALITY OF LIFE AND 44% REDUCTION IN HEART FAILURE HOSPITALIZATIONS

EUROPEAN STUDY FINDS THE ABBOTT CARDIOMEMS SENSOR RESULTS IN IMPROVED QUALITY OF LIFE AND 44% REDUCTION IN HEART FAILURE HOSPITALIZATIONS New data presented from an investigator-sponsored European trial found managing indicated1 heart failure patients with Abbott’s CardioMEMS™ HF System resulted in a significant1 improvement…

Read MoreEUROPEAN STUDY FINDS THE ABBOTT CARDIOMEMS SENSOR RESULTS IN IMPROVED QUALITY OF LIFE AND 44% REDUCTION IN HEART FAILURE HOSPITALIZATIONS

GSK’s respiratory syncytial virus older adult vaccine candidate gains positive European Medicines Agency CHMP opinion

GSK’s respiratory syncytial virus older adult vaccine candidate gains positive European Medicines Agency CHMP opinion GSK plc (LSE/NYSE: GSK) today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion by…

Read MoreGSK’s respiratory syncytial virus older adult vaccine candidate gains positive European Medicines Agency CHMP opinion